(-)-demecolcine increases expression ISO RGD:737055 6480464 Demecolcine results in increased expression of SLC2A3 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:737055 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC2A3 mRNA more ... CTD PMID:22079256 , PMID:31857147 (-)-epigallocatechin 3-gallate increases expression ISO RGD:737055 6480464 epigallocatechin gallate results in increased expression of SLC2A3 mRNA, epigallocatechin gallate results in increased expression of SLC2A3 protein CTD PMID:31857147 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SLC2A3 mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of SLC2A3 mRNA CTD PMID:22206623 1,4-phenylenediamine increases expression ISO RGD:737055 6480464 4-phenylenediamine results in increased expression of SLC2A3 mRNA CTD PMID:19371601 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine decreases expression ISO RGD:737055 6480464 chlorcyclizine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile decreases expression ISO RGD:737055 6480464 Citalopram results in decreased expression of SLC2A3 mRNA CTD PMID:17567588 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:737055 6480464 Dinitrochlorobenzene results in increased expression of SLC2A3 mRNA CTD PMID:17374397 1-chloro-2,4-dinitrobenzene decreases expression ISO RGD:737055 6480464 Dinitrochlorobenzene results in decreased expression of SLC2A3 mRNA CTD PMID:19371601 1-fluoro-2,4-dinitrobenzene increases expression ISO RGD:737055 6480464 Dinitrofluorobenzene results in increased expression of SLC2A3 mRNA CTD PMID:21362464 17beta-estradiol decreases expression ISO RGD:737055 6480464 Estradiol results in decreased expression of SLC2A3 mRNA CTD PMID:20106945 , PMID:21632981 17beta-estradiol multiple interactions ISO RGD:737055 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC2A3 mRNA CTD PMID:30165855 17beta-estradiol 3-benzoate decreases methylation ISO RGD:3706 6480464 estradiol 3-benzoate results in decreased methylation of SLC2A3 promoter CTD PMID:27415467 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:737055 6480464 Dihydrotestosterone results in increased expression of SLC2A3 mRNA CTD PMID:29581250 2,3',4,4',5-Pentachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC2A3 protein CTD PMID:17872374 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:3706 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC2A3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737055 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC2A3 mRNA CTD PMID:16704738 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC2A3 mRNA CTD PMID:17872374 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:3706 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC2A3 mRNA CTD PMID:11858732 , PMID:34747641 2,4-D increases expression ISO RGD:3706 6480464 2, 4-Dichlorophenoxyacetic Acid results in increased expression of SLC2A3 mRNA CTD PMID:23538319 2,4-D decreases expression ISO RGD:3706 6480464 2 more ... CTD PMID:23538319 2,6-di-tert-butyl-4-methylphenol decreases expression EXP 6480464 Butylated Hydroxytoluene results in decreased expression of SLC2A3 mRNA CTD PMID:19925653 2-deoxy-D-glucose multiple interactions ISO RGD:737055 6480464 Cytochalasin B inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] more ... CTD PMID:8457197 2-deoxy-D-glucose increases transport ISO RGD:737055 6480464 SLC2A3 protein results in increased transport of Deoxyglucose CTD PMID:8457197 2-hydroxypropanoic acid affects expression ISO RGD:737055 6480464 Lactic Acid affects the expression of SLC2A3 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:3706 6480464 3 more ... CTD PMID:23196670 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of SLC2A3 mRNA CTD PMID:20188158 3,7-dihydropurine-6-thione decreases expression ISO RGD:3706 6480464 Mercaptopurine results in decreased expression of SLC2A3 mRNA CTD PMID:23358152 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SLC2A3 mRNA CTD PMID:30951980 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:737055 6480464 Oxazolone results in increased expression of SLC2A3 mRNA CTD PMID:17374397 5-fluorouracil affects response to substance ISO RGD:737055 6480464 SLC2A3 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 6-propyl-2-thiouracil increases expression ISO RGD:3706 6480464 Propylthiouracil results in increased expression of SLC2A3 mRNA CTD PMID:18077114 aflatoxin B1 decreases methylation ISO RGD:737055 6480464 Aflatoxin B1 results in decreased methylation of SLC2A3 3' UTR, Aflatoxin B1 results in decreased methylation of SLC2A3 intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions ISO RGD:737055 6480464 [INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein more ... CTD PMID:28951307 , PMID:8457197 aldehydo-D-glucose multiple interactions ISO RGD:3706 6480464 [Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein, N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein] CTD PMID:24726522 all-trans-retinoic acid increases expression ISO RGD:737055 6480464 Tretinoin results in increased expression of SLC2A3 mRNA CTD PMID:16054129 , PMID:33167477 all-trans-retinoic acid decreases expression ISO RGD:737055 6480464 Tretinoin results in decreased expression of SLC2A3 mRNA CTD PMID:16168501 alpha-D-galactose increases transport ISO RGD:737055 6480464 SLC2A3 protein results in increased transport of Galactose CTD PMID:8457197 alpha-D-galactose multiple interactions ISO RGD:737055 6480464 Galactose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] more ... CTD PMID:8457197 amiodarone decreases expression ISO RGD:737055 6480464 Amiodarone results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 more ... amitriptyline decreases expression ISO RGD:737055 6480464 Amitriptyline results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 more ... ammonium chloride affects expression ISO RGD:3706 6480464 Ammonium Chloride affects the expression of SLC2A3 mRNA CTD PMID:16483693 ampicillin increases expression ISO RGD:737055 6480464 Ampicillin results in increased expression of SLC2A3 mRNA CTD PMID:21632981 antimonite multiple interactions ISO RGD:737055 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SLC2A3 mRNA CTD PMID:32076005 antirheumatic drug decreases expression ISO RGD:737055 6480464 Antirheumatic Agents results in decreased expression of SLC2A3 mRNA CTD PMID:24449571 apigenin multiple interactions ISO RGD:737055 6480464 [Apigenin co-treated with Oxygen deficiency] results in decreased expression of SLC2A3 mRNA CTD PMID:20153296 Archazolid B increases expression ISO RGD:737055 6480464 archazolid B results in increased expression of SLC2A3 mRNA CTD PMID:25218289 arsane multiple interactions ISO RGD:737055 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC2A3 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:737055 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC2A3 mRNA CTD PMID:32525701 arsenous acid increases expression ISO RGD:737055 6480464 Arsenic Trioxide results in increased expression of SLC2A3 mRNA CTD PMID:22521957 , PMID:25258189 avobenzone increases expression ISO RGD:737055 6480464 avobenzone results in increased expression of SLC2A3 mRNA CTD PMID:31016361 benzo[a]pyrene decreases expression ISO RGD:737055 6480464 Benzo(a)pyrene results in decreased expression of SLC2A3 mRNA CTD PMID:20106945 more ... benzo[a]pyrene affects methylation ISO RGD:737055 6480464 Benzo(a)pyrene affects the methylation of SLC2A3 intron CTD PMID:30157460 benzo[e]pyrene increases methylation ISO RGD:737055 6480464 benzo(e)pyrene results in increased methylation of SLC2A3 intron CTD PMID:30157460 Benzo[k]fluoranthene increases expression EXP 6480464 benzo(k)fluoranthene results in increased expression of SLC2A3 mRNA CTD PMID:26377693 benzoates increases expression ISO RGD:737055 6480464 Benzoates analog results in increased expression of SLC2A3 mRNA CTD PMID:29472718 beta-maltose multiple interactions ISO RGD:737055 6480464 Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose], Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Galactose] CTD PMID:8457197 bis(2-ethylhexyl) phthalate increases expression ISO RGD:737055 6480464 Diethylhexyl Phthalate results in increased expression of SLC2A3 mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC2A3 mRNA CTD PMID:24909818 , PMID:26063408 bisphenol A decreases methylation ISO RGD:737055 6480464 bisphenol A results in decreased methylation of SLC2A3 gene CTD PMID:31601247 bisphenol A affects expression ISO RGD:737055 6480464 bisphenol A affects the expression of SLC2A3 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:3706 6480464 bisphenol A results in decreased expression of SLC2A3 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC2A3 mRNA, bisphenol A results in decreased expression of SLC2A3 protein CTD PMID:25637671 more ... bortezomib increases expression ISO RGD:737055 6480464 Bortezomib results in increased expression of SLC2A3 mRNA CTD PMID:20977926 buta-1,3-diene decreases expression EXP 6480464 1, 3-butadiene results in decreased expression of SLC2A3 mRNA CTD PMID:21147608 butanal decreases expression ISO RGD:737055 6480464 butyraldehyde results in decreased expression of SLC2A3 mRNA CTD PMID:26079696 cadmium atom decreases expression ISO RGD:737055 6480464 Cadmium results in decreased expression of SLC2A3 mRNA CTD PMID:21120746 cadmium dichloride multiple interactions ISO RGD:737055 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of SLC2A3 mRNA CTD PMID:12634122 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SLC2A3 mRNA CTD PMID:30615929 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of SLC2A3 promoter CTD PMID:27984135 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of SLC2A3 mRNA, Cadmium Chloride results in decreased expression of SLC2A3 protein CTD PMID:27984135 cadmium dichloride decreases expression ISO RGD:737055 6480464 Cadmium Chloride results in decreased expression of SLC2A3 mRNA CTD PMID:26314618 caffeine increases expression ISO RGD:737055 6480464 Caffeine results in increased expression of SLC2A3 protein CTD PMID:25486098 caffeine affects phosphorylation ISO RGD:737055 6480464 Caffeine affects the phosphorylation of SLC2A3 protein CTD PMID:35688186 calcitriol increases expression ISO RGD:737055 6480464 Calcitriol results in increased expression of SLC2A3 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:737055 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SLC2A3 mRNA CTD PMID:21592394 cannabidiol increases expression ISO RGD:737055 6480464 Cannabidiol results in increased expression of SLC2A3 mRNA CTD PMID:31518892 carbamazepine affects expression ISO RGD:737055 6480464 Carbamazepine affects the expression of SLC2A3 mRNA CTD PMID:25979313 chlorpromazine decreases expression ISO RGD:737055 6480464 Chlorpromazine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 chromium atom multiple interactions ISO RGD:3706 6480464 Chromium inhibits the reaction [Dietary Fats results in decreased expression of SLC2A3 protein] CTD PMID:21120707 cisplatin increases phosphorylation EXP 6480464 Cisplatin results in increased phosphorylation of SLC2A3 protein CTD PMID:22006019 cisplatin increases expression ISO RGD:737055 6480464 Cisplatin results in increased expression of SLC2A3 mRNA CTD PMID:27594783 citalopram decreases expression ISO RGD:737055 6480464 Citalopram results in decreased expression of SLC2A3 mRNA CTD PMID:17567588 clomipramine decreases expression ISO RGD:737055 6480464 Clomipramine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 , PMID:17175557 clozapine decreases expression ISO RGD:737055 6480464 Clozapine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 cobalt dichloride increases expression ISO RGD:737055 6480464 cobaltous chloride results in increased expression of SLC2A3 mRNA CTD PMID:19320972 , PMID:19376846 copper atom multiple interactions ISO RGD:737055 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of SLC2A3 mRNA CTD PMID:25167922 copper(0) multiple interactions ISO RGD:737055 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of SLC2A3 mRNA CTD PMID:25167922 crocidolite asbestos increases expression ISO RGD:737055 6480464 Asbestos, Crocidolite results in increased expression of SLC2A3 mRNA CTD PMID:25351596 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of SLC2A3 mRNA CTD PMID:21397623 cyclosporin A increases expression ISO RGD:3706 6480464 Cyclosporine results in increased expression of SLC2A3 mRNA CTD PMID:19224547 cyclosporin A decreases expression ISO RGD:737055 6480464 Cyclosporine results in decreased expression of SLC2A3 mRNA CTD PMID:20106945 more ... cytochalasin B multiple interactions ISO RGD:737055 6480464 Cytochalasin B inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] CTD PMID:8457197 D-glucose multiple interactions ISO RGD:737055 6480464 [INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein more ... CTD PMID:28951307 , PMID:8457197 D-glucose multiple interactions ISO RGD:3706 6480464 [Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein, N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein] CTD PMID:24726522 decabromodiphenyl ether increases expression ISO RGD:3706 6480464 decabromobiphenyl ether results in increased expression of SLC2A3 mRNA CTD PMID:23914054 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of SLC2A3 protein CTD PMID:28572024 , PMID:31039416 dehydroascorbic acid affects transport ISO RGD:737055 6480464 SLC2A3 protein affects the transport of Dehydroascorbic Acid CTD PMID:15590689 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC2A3 mRNA CTD PMID:29950665 diarsenic trioxide increases expression ISO RGD:737055 6480464 Arsenic Trioxide results in increased expression of SLC2A3 mRNA CTD PMID:22521957 , PMID:25258189 dibutyl phthalate increases expression ISO RGD:3706 6480464 Dibutyl Phthalate results in increased expression of SLC2A3 mRNA CTD PMID:21266533 dichromium trioxide multiple interactions ISO RGD:737055 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of SLC2A3 mRNA CTD PMID:12634122 dioxygen multiple interactions ISO RGD:737055 6480464 [Apigenin co-treated with Oxygen deficiency] results in decreased expression of SLC2A3 mRNA more ... CTD PMID:17442736 more ... dioxygen multiple interactions ISO RGD:3706 6480464 [Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein more ... CTD PMID:23307114 more ... dioxygen increases expression ISO RGD:3706 6480464 Oxygen deficiency results in increased expression of SLC2A3 mRNA CTD PMID:23307114 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of SLC2A3 mRNA CTD PMID:20880076 dioxygen increases expression ISO RGD:737055 6480464 Oxygen deficiency results in increased expression of SLC2A3 mRNA, Oxygen deficiency results in increased expression of SLC2A3 protein CTD PMID:17442736 more ... dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:737055 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SLC2A3 mRNA CTD PMID:32076005 divanadium pentaoxide affects expression ISO RGD:737055 6480464 vanadium pentoxide affects the expression of SLC2A3 mRNA CTD PMID:17459161 dorsomorphin multiple interactions ISO RGD:737055 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxepin decreases expression ISO RGD:737055 6480464 Doxepin results in decreased expression of SLC2A3 mRNA CTD PMID:17567588 doxorubicin decreases expression ISO RGD:737055 6480464 Doxorubicin results in decreased expression of SLC2A3 mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:737055 6480464 entinostat results in increased expression of SLC2A3 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:737055 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of SLC2A3 mRNA CTD PMID:30319688 eugenol increases expression ISO RGD:737055 6480464 Eugenol results in increased expression of SLC2A3 mRNA CTD PMID:17374397 fisetin multiple interactions ISO RGD:737055 6480464 [fisetin co-treated with Oxygen deficiency] results in decreased expression of SLC2A3 mRNA CTD PMID:20153296 flecainide decreases expression ISO RGD:737055 6480464 Flecainide results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 flecainide increases expression ISO RGD:737055 6480464 Flecainide results in increased expression of SLC2A3 mRNA CTD PMID:17175557 fluoxetine decreases expression ISO RGD:737055 6480464 Fluoxetine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 , PMID:17567588 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SLC2A3 mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:737055 6480464 Formaldehyde results in increased expression of SLC2A3 mRNA CTD PMID:27664576 galactose multiple interactions ISO RGD:737055 6480464 Galactose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose] more ... CTD PMID:8457197 galactose increases transport ISO RGD:737055 6480464 SLC2A3 protein results in increased transport of Galactose CTD PMID:8457197 gemcitabine increases expression ISO RGD:737055 6480464 Gemcitabine results in increased expression of SLC2A3 mRNA CTD PMID:17039268 genistein decreases expression ISO RGD:3706 6480464 Genistein results in decreased expression of SLC2A3 mRNA CTD PMID:21782745 gentamycin decreases expression ISO RGD:3706 6480464 Gentamicins results in decreased expression of SLC2A3 mRNA CTD PMID:33387578 glucose multiple interactions ISO RGD:737055 6480464 [INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein more ... CTD PMID:28951307 , PMID:8457197 glucose multiple interactions ISO RGD:3706 6480464 [Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein, N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein] CTD PMID:24726522 imidacloprid increases expression ISO RGD:3706 6480464 imidacloprid results in increased expression of SLC2A3 mRNA CTD PMID:27782041 imipramine decreases expression ISO RGD:737055 6480464 Imipramine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 , PMID:17567588 ketoconazole decreases expression ISO RGD:737055 6480464 Ketoconazole results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 , PMID:17567588 kynurenic acid multiple interactions ISO RGD:737055 6480464 Kynurenic Acid inhibits the reaction [[INS protein co-treated with Glucose] results in decreased expression of SLC2A3 protein] CTD PMID:28951307 L-dehydroascorbic acid affects transport ISO RGD:737055 6480464 SLC2A3 protein affects the transport of Dehydroascorbic Acid CTD PMID:15590689 lead diacetate multiple interactions ISO RGD:737055 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 mRNA more ... CTD PMID:12634122 , PMID:31874198 lead diacetate multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 protein CTD PMID:34508822 lead diacetate increases methylation ISO RGD:3706 6480464 lead acetate results in increased methylation of SLC2A3 gene CTD PMID:29571894 lead diacetate increases expression ISO RGD:3706 6480464 lead acetate results in increased expression of SLC2A3 mRNA, lead acetate results in increased expression of SLC2A3 protein CTD PMID:30980912 lead(0) multiple interactions ISO RGD:737055 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 mRNA more ... CTD PMID:31874198 lead(0) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 protein CTD PMID:34508822 lead(2+) multiple interactions ISO RGD:737055 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 mRNA more ... CTD PMID:31874198 lead(2+) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 protein CTD PMID:34508822 lipopolysaccharide increases expression ISO RGD:737055 6480464 Lipopolysaccharides results in increased expression of SLC2A3 mRNA CTD PMID:21362464 lipopolysaccharide multiple interactions ISO RGD:737055 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLC2A3 mRNA CTD PMID:35811015 loratadine decreases expression ISO RGD:737055 6480464 Loratadine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 , PMID:17567588 luteolin multiple interactions ISO RGD:737055 6480464 [Luteolin co-treated with Oxygen deficiency] results in decreased expression of SLC2A3 mRNA CTD PMID:20153296 maltose multiple interactions ISO RGD:737055 6480464 Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose], Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Galactose] CTD PMID:8457197 menadione decreases expression EXP 6480464 Vitamin K 3 results in decreased expression of SLC2A3 mRNA CTD PMID:25270620 mercaptopurine decreases expression ISO RGD:3706 6480464 Mercaptopurine results in decreased expression of SLC2A3 mRNA CTD PMID:23358152 mercury dibromide increases expression ISO RGD:737055 6480464 mercuric bromide results in increased expression of SLC2A3 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:737055 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 mercury dichloride increases expression ISO RGD:3706 6480464 Mercuric Chloride results in increased expression of SLC2A3 mRNA CTD PMID:32599119 metacetamol decreases expression EXP 6480464 3-hydroxyacetanilide results in decreased expression of SLC2A3 mRNA CTD PMID:18544908 methapyrilene increases methylation ISO RGD:737055 6480464 Methapyrilene results in increased methylation of SLC2A3 intron CTD PMID:30157460 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of SLC2A3 mRNA CTD PMID:18502557 methotrexate decreases expression ISO RGD:737055 6480464 Methotrexate results in decreased expression of SLC2A3 mRNA CTD PMID:24449571 methylmercury chloride increases expression ISO RGD:737055 6480464 methylmercuric chloride results in increased expression of SLC2A3 mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:737055 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 methylmercury chloride decreases expression ISO RGD:737055 6480464 methylmercuric chloride results in decreased expression of SLC2A3 mRNA CTD PMID:23179753 , PMID:27188386 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:3706 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein] CTD PMID:24726522 N-acetyl-beta-D-glucosamine decreases expression ISO RGD:737055 6480464 Acetylglucosamine results in decreased expression of SLC2A3 mRNA CTD PMID:18047607 N-acetyl-beta-D-glucosamine increases expression ISO RGD:737055 6480464 Acetylglucosamine results in increased expression of SLC2A3 mRNA CTD PMID:18047607 N-acetyl-D-glucosamine decreases expression ISO RGD:737055 6480464 Acetylglucosamine results in decreased expression of SLC2A3 mRNA CTD PMID:18047607 N-acetyl-D-glucosamine increases expression ISO RGD:737055 6480464 Acetylglucosamine results in increased expression of SLC2A3 mRNA CTD PMID:18047607 N-acetyl-L-cysteine multiple interactions ISO RGD:737055 6480464 Acetylcysteine inhibits the reaction [epigallocatechin gallate results in increased expression of SLC2A3 mRNA], Acetylcysteine inhibits the reaction [epigallocatechin gallate results in increased expression of SLC2A3 protein] CTD PMID:31857147 nickel atom increases expression ISO RGD:737055 6480464 Nickel results in increased expression of SLC2A3 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride increases expression ISO RGD:737055 6480464 nickel chloride results in increased expression of SLC2A3 mRNA CTD PMID:17312168 nickel sulfate increases expression ISO RGD:737055 6480464 nickel sulfate results in increased expression of SLC2A3 mRNA CTD PMID:16780908 , PMID:17374397 niclosamide decreases expression ISO RGD:737055 6480464 Niclosamide results in decreased expression of SLC2A3 mRNA CTD PMID:22576131 organoselenium compound multiple interactions ISO RGD:737055 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of SLC2A3 mRNA CTD PMID:25167922 oxaliplatin decreases expression ISO RGD:737055 6480464 oxaliplatin results in decreased expression of SLC2A3 mRNA CTD PMID:17762391 oxaliplatin multiple interactions ISO RGD:3706 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC2A3 mRNA CTD PMID:25729387 p-chloromercuribenzoic acid increases expression ISO RGD:737055 6480464 p-Chloromercuribenzoic Acid results in increased expression of SLC2A3 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:737055 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:737055 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:737055 6480464 panobinostat results in increased expression of SLC2A3 mRNA CTD PMID:26272509 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC2A3 mRNA CTD PMID:18544908 paracetamol decreases expression ISO RGD:3706 6480464 Acetaminophen results in decreased expression of SLC2A3 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:737055 6480464 Acetaminophen results in decreased expression of SLC2A3 mRNA CTD PMID:17175557 paracetamol increases expression ISO RGD:737055 6480464 Acetaminophen results in increased expression of SLC2A3 mRNA CTD PMID:21420995 paraquat increases expression ISO RGD:3706 6480464 Paraquat results in increased expression of SLC2A3 mRNA CTD PMID:18198484 pentamidine decreases expression ISO RGD:737055 6480464 Pentamidine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 pentanal decreases expression ISO RGD:737055 6480464 pentanal results in decreased expression of SLC2A3 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of SLC2A3 protein CTD PMID:26178269 perfluorooctanoic acid decreases expression ISO RGD:737055 6480464 perfluorooctanoic acid results in decreased expression of SLC2A3 protein CTD PMID:26879310 perhexiline decreases expression ISO RGD:737055 6480464 Perhexiline results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 perhexiline increases expression ISO RGD:737055 6480464 Perhexiline results in increased expression of SLC2A3 mRNA CTD PMID:17175557 phenylmercury acetate increases expression ISO RGD:737055 6480464 Phenylmercuric Acetate results in increased expression of SLC2A3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:737055 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 pioglitazone multiple interactions ISO RGD:737055 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA CTD PMID:20847119 potassium chromate multiple interactions ISO RGD:737055 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC2A3 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:737055 6480464 potassium chromate(VI) results in increased expression of SLC2A3 mRNA CTD PMID:22079256 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of SLC2A3 mRNA CTD PMID:23608068 progesterone affects expression EXP 6480464 Progesterone affects the expression of SLC2A3 mRNA CTD PMID:17251523 progesterone increases expression EXP 6480464 Progesterone results in increased expression of SLC2A3 mRNA CTD PMID:22238285 progesterone multiple interactions ISO RGD:3706 6480464 Progesterone promotes the reaction [Oxygen deficiency results in increased expression of SLC2A3 mRNA] CTD PMID:23307114 purine-6-thiol decreases expression ISO RGD:3706 6480464 Mercaptopurine results in decreased expression of SLC2A3 mRNA CTD PMID:23358152 quercetin decreases expression ISO RGD:737055 6480464 Quercetin results in decreased expression of SLC2A3 mRNA CTD PMID:21632981 quinidine decreases expression ISO RGD:737055 6480464 Quinidine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 , PMID:17567588 rac-lactic acid affects expression ISO RGD:737055 6480464 Lactic Acid affects the expression of SLC2A3 mRNA CTD PMID:30851411 raloxifene affects expression ISO RGD:737055 6480464 Raloxifene Hydrochloride affects the expression of SLC2A3 mRNA CTD PMID:14699072 resorcinol increases expression ISO RGD:737055 6480464 resorcinol results in increased expression of SLC2A3 mRNA CTD PMID:22623647 rotenone decreases expression ISO RGD:737055 6480464 Rotenone results in decreased expression of SLC2A3 mRNA CTD PMID:36586010 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:737055 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLC2A3 mRNA CTD PMID:35811015 SB 431542 increases expression ISO RGD:737055 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC2A3 protein CTD PMID:25670856 SB 431542 multiple interactions ISO RGD:737055 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine increases expression EXP 6480464 senecionine results in increased expression of SLC2A3 protein CTD PMID:35357534 serpentine asbestos increases expression ISO RGD:737055 6480464 Asbestos, Serpentine results in increased expression of SLC2A3 mRNA CTD PMID:29523930 sertraline decreases expression ISO RGD:737055 6480464 Sertraline results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 , PMID:17567588 silicon dioxide increases expression ISO RGD:737055 6480464 Silicon Dioxide results in increased expression of SLC2A3 mRNA CTD PMID:25351596 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of SLC2A3 mRNA CTD PMID:29341224 silicon dioxide decreases expression ISO RGD:737055 6480464 Silicon Dioxide results in decreased expression of SLC2A3 mRNA CTD PMID:28425640 sodium arsenate multiple interactions ISO RGD:737055 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC2A3 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO RGD:737055 6480464 sodium arsenite results in decreased expression of SLC2A3 mRNA CTD PMID:12634122 , PMID:29301061 sodium arsenite increases expression ISO RGD:737055 6480464 sodium arsenite results in increased expression of SLC2A3 mRNA CTD PMID:34032870 sodium arsenite multiple interactions ISO RGD:737055 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of SLC2A3 mRNA CTD PMID:12634122 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of SLC2A3 mRNA CTD PMID:26876454 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of SLC2A3 protein CTD PMID:28918527 sotalol increases expression ISO RGD:737055 6480464 Sotalol results in increased expression of SLC2A3 mRNA CTD PMID:15342952 sotorasib multiple interactions ISO RGD:737055 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SLC2A3 mRNA CTD PMID:36139627 sulforaphane increases expression ISO RGD:737055 6480464 sulforaphane results in increased expression of SLC2A3 mRNA CTD PMID:26833863 sunitinib increases expression ISO RGD:737055 6480464 Sunitinib results in increased expression of SLC2A3 mRNA CTD PMID:31533062 tamoxifen decreases expression ISO RGD:737055 6480464 Tamoxifen results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 , PMID:17567588 tamoxifen increases expression ISO RGD:3706 6480464 Tamoxifen results in increased expression of SLC2A3 mRNA CTD PMID:19224547 tamoxifen affects expression ISO RGD:737055 6480464 Tamoxifen affects the expression of SLC2A3 mRNA CTD PMID:14699072 tert-butyl hydroperoxide multiple interactions ISO RGD:737055 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA more ... CTD PMID:20847119 tert-butyl hydroperoxide increases expression ISO RGD:737055 6480464 tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA CTD PMID:20847119 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Testosterone deficiency results in decreased expression of SLC2A3 mRNA] CTD PMID:21045173 testosterone increases expression EXP 6480464 Testosterone results in increased expression of SLC2A3 mRNA CTD PMID:20403060 testosterone multiple interactions ISO RGD:737055 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SLC2A3 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:737055 6480464 Testosterone results in increased expression of SLC2A3 mRNA CTD PMID:21592394 tetrachloromethane decreases expression ISO RGD:3706 6480464 Carbon Tetrachloride results in decreased expression of SLC2A3 mRNA CTD PMID:16644059 tetrachloromethane affects expression ISO RGD:3706 6480464 Carbon Tetrachloride affects the expression of SLC2A3 mRNA CTD PMID:12734012 tetrachloromethane increases expression ISO RGD:3706 6480464 Carbon Tetrachloride results in increased expression of SLC2A3 mRNA CTD PMID:19224547 tetracycline increases expression ISO RGD:3706 6480464 Tetracycline results in increased expression of SLC2A3 mRNA CTD PMID:19224547 thalidomide increases expression EXP 6480464 Thalidomide results in increased expression of SLC2A3 mRNA CTD PMID:26217789 thimerosal decreases expression ISO RGD:737055 6480464 Thimerosal results in decreased expression of SLC2A3 mRNA CTD PMID:27188386 thioridazine decreases expression ISO RGD:737055 6480464 Thioridazine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC2A3 mRNA CTD PMID:29950665 topotecan increases expression ISO RGD:3706 6480464 Topotecan results in increased expression of SLC2A3 mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:3706 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC2A3 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:737055 6480464 torcetrapib results in increased expression of SLC2A3 mRNA CTD PMID:23228038 trametinib multiple interactions ISO RGD:737055 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SLC2A3 mRNA CTD PMID:36139627 tributylstannane decreases expression ISO RGD:737055 6480464 tributyltin results in decreased expression of SLC2A3 mRNA CTD PMID:19371601 trichostatin A increases expression ISO RGD:737055 6480464 trichostatin A results in increased expression of SLC2A3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A affects expression ISO RGD:737055 6480464 trichostatin A affects the expression of SLC2A3 mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO RGD:737055 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:737055 6480464 Triclosan results in decreased expression of SLC2A3 mRNA CTD PMID:30510588 Triptolide affects expression EXP 6480464 triptolide affects the expression of SLC2A3 mRNA CTD PMID:34087332 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of SLC2A3 mRNA, triptolide results in decreased expression of SLC2A3 protein CTD PMID:34087332 triptonide increases expression EXP 6480464 triptonide results in increased expression of SLC2A3 mRNA CTD PMID:33045310 troglitazone multiple interactions ISO RGD:737055 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA, troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA] CTD PMID:20847119 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of SLC2A3 mRNA CTD PMID:30912803 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of SLC2A3 mRNA CTD PMID:24370435 uranium atom affects expression ISO RGD:737055 6480464 Uranium affects the expression of SLC2A3 mRNA CTD PMID:15672453 urethane decreases expression ISO RGD:737055 6480464 Urethane results in decreased expression of SLC2A3 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:737055 6480464 Valproic Acid results in increased expression of SLC2A3 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:737055 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 vandetanib increases expression ISO RGD:737055 6480464 vandetanib results in increased expression of SLC2A3 mRNA CTD PMID:16052530 vorinostat multiple interactions ISO RGD:737055 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC2A3 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:737055 6480464 vorinostat results in increased expression of SLC2A3 mRNA CTD PMID:26272509 XL147 multiple interactions EXP 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC2A3 mRNA CTD PMID:27935865 Yessotoxin increases expression ISO RGD:737055 6480464 yessotoxin analog results in increased expression of SLC2A3 mRNA CTD PMID:30679557 zidovudine decreases expression ISO RGD:737055 6480464 Zidovudine results in decreased expression of SLC2A3 mRNA CTD PMID:24292225 zinc atom multiple interactions ISO RGD:737055 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SLC2A3 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:737055 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SLC2A3 mRNA CTD PMID:18593933
